Kristen Sheridan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kristen Sheridan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- David C. Hooper
Infectious Diseases Division and Medical Services, Massachusetts General Hospital
1 shared publication - David Flynn
Department of Medical Sciences and Education, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, United States of America
1 shared publication - David Roach
Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, USA
1 shared publication - Edwin Wilbur Woodhouse
Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine , Durham, North Carolina
1 shared publication - Erin M. Duffy
CARB-X, Boston University , Boston, Massachusetts
1 shared publication John P. Heggers
Shriners Hospitals for Children#TAB
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (7) , ofaf365
Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysis
Background: Infections following colonization of multidrug-resistant gram-negative bacteria (MDR-GNB), particularly Enterobacterales with extended-spectrum beta-lactamases (ESBL-E) or carbapenem-resistant Enterobacterales (CRE), represent a major global health threat. Our aim was to assess quality of evidence and provide estimates on rate of infection following colonization with multidrug-resistant gram-negative bacteria. Methods: We performed an umbrella review of systematic reviews and meta-analyses. Quality was assessed using the AMSTAR 2 tool, and a meta-analysis was performed to estimate rate of infection. Results: An initial search for systematic reviews and meta-analyses yielded 847 results, with 17 articles ultimately included. After exclusion of 2 studies for overlapping results and very low quality, the pooled incidence of infection following colonization across the studies was 22% for ESBL-E and 22% for CRE. Few reviews included high-quality findings on mortality or transmission following colonization. Additionally, only a limited number of reviews included findings related to MDR Pseudomonas aeruginosa or carbapenem-resistant Acinetobacter baumannii. Conclusions: Our results suggest a substantial rate of infection following colonization of multidrug-resistant gram-negative bacteria. These findings can inform individual patient counseling, future decolonization innovation, clinical trial design, and regulatory approval of new decolonization agents. However, the heterogeneity of the included populations may limit the generalizability of these findings.
- 30 June 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (7) , ofaf365
Open AccessInfection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysis
Background: Infections following colonization of multidrug-resistant gram-negative bacteria (MDR-GNB), particularly Enterobacterales with extended-spectrum beta-lactamases (ESBL-E) or carbapenem-resistant Enterobacterales (CRE), represent a major global health threat. Our aim was to assess quality of evidence and provide estimates on rate of infection following colonization with multidrug-resistant gram-negative bacteria. Methods: We performed an umbrella review of systematic reviews and meta-analyses. Quality was assessed using the AMSTAR 2 tool, and a meta-analysis was performed to estimate rate of infection. Results: An initial search for systematic reviews and meta-analyses yielded 847 results, with 17 articles ultimately included. After exclusion of 2 studies for overlapping results and very low quality, the pooled incidence of infection following colonization across the studies was 22% for ESBL-E and 22% for CRE. Few reviews included high-quality findings on mortality or transmission following colonization. Additionally, only a limited number of reviews included findings related to MDR Pseudomonas aeruginosa or carbapenem-resistant Acinetobacter baumannii. Conclusions: Our results suggest a substantial rate of infection following colonization of multidrug-resistant gram-negative bacteria. These findings can inform individual patient counseling, future decolonization innovation, clinical trial design, and regulatory approval of new decolonization agents. However, the heterogeneity of the included populations may limit the generalizability of these findings.
- 1 March 2001
- Published by Oxford University Press (OUP) in Journal of Burn Care & Rehabilitation
- Vol. 22 (2) , 124-127
Cadaver Donor Discards Secondary to Serology
The use of cadaveric skin has made a major impact in the survival of patients experiencing major thermal injury. However, the availability of cadaveric skin is often limited by potentially pathogenic organisms. Very little data exists as to why cadaveric skin from donors who have been previously screened was discarded. From March 1994 to March 1996, 813 donors were referred to our tissue bank. All donors were reviewed for the cause of death, history and physical, and social history. One hundred fifty-three donors screened were discarded. Sixty-one donors of this group were discarded because of positive serologies. The following are the percentages of the specific positive serologies: hepatitis B core antibody, 52.3%; hepatitis B surface antigen, 18.1%; hepatitis C virus antibody, 14.3%; human immunodeficiency virus antibody, 4.9%; human T lymphocyte virus antibody, 4.9% and syphilis, 5.5%. Retrospectively, all donor screening questionnaires were reviewed for possible indicators in relation to positive serologic testing. Current screening methods, although excellent in social screening, still fail to identify a significant number of donors who may have positive serologies because of hepatitis, human immunodeficiency virus, human T lymphocyte virus, or syphilis. As the field of tissue banking continues to evolve, the focus will need to be directed toward better screening mechanisms in order to decrease our current discard rates after donors have been approved through the screening process.
- 1 March 2001
- Published by Oxford University Press (OUP) in Journal of Burn Care & Rehabilitation
- Vol. 22 (2) , 124-127
Cadaver Donor Discards Secondary to Serology
The use of cadaveric skin has made a major impact in the survival of patients experiencing major thermal injury. However, the availability of cadaveric skin is often limited by potentially pathogenic organisms. Very little data exists as to why cadaveric skin from donors who have been previously screened was discarded. From March 1994 to March 1996, 813 donors were referred to our tissue bank. All donors were reviewed for the cause of death, history and physical, and social history. One hundred fifty-three donors screened were discarded. Sixty-one donors of this group were discarded because of positive serologies. The following are the percentages of the specific positive serologies: hepatitis B core antibody, 52.3%; hepatitis B surface antigen, 18.1%; hepatitis C virus antibody, 14.3%; human immunodeficiency virus antibody, 4.9%; human T lymphocyte virus antibody, 4.9% and syphilis, 5.5%. Retrospectively, all donor screening questionnaires were reviewed for possible indicators in relation to positive serologic testing. Current screening methods, although excellent in social screening, still fail to identify a significant number of donors who may have positive serologies because of hepatitis, human immunodeficiency virus, human T lymphocyte virus, or syphilis. As the field of tissue banking continues to evolve, the focus will need to be directed toward better screening mechanisms in order to decrease our current discard rates after donors have been approved through the screening process.